[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.

Positive

• None.

Negative

• Reported sale of 30,000 common shares executed on 09/17/2025 at a weighted average price of $41.719 per share
• Reduction in direct holdings by the 30,000-share sale (reported as a disposal)

Insights

Financial Analyst

TL;DR: Insider sale of 30,000 shares under a 10b5-1 plan; substantial trust holdings and vested options remain.

The filing documents a planned disposition executed under a Rule 10b5-1 plan, which provides procedural protection against accusations of trading on material nonpublic information. The reported weighted average sale price was $41.719 per share. While the sale reduces direct holdings by 30,000 shares, the reporting person continues to hold large indirect and direct positions through trusts totaling over 2.1 million shares combined as reported. Several non-qualified stock options with varied strike prices and vesting schedules are outstanding, including options fully vested and exercisable, which could affect future dilution if exercised.

Corporate Governance Expert

TL;DR: Transaction follows a documented 10b5-1 plan; disclosure aligns with Section 16 reporting requirements.

The Form 4 is properly filed and includes standard explanatory footnotes identifying the trading plan and trust ownership. The signature by an attorney-in-fact is provided. The disclosure of option vesting schedules and exercisability is appropriate for transparency around potential future insider-driven equity changes. No amendments or unusual reporting flags are present in the filing text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		S(1)		30,000	D	$41.719(2)	1,549,049	I	by M. Kirban 2010(3)
Common Stock								127,629	D
Common Stock								615,681	I	by M. Kirban Revoc(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(5)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (right to buy)	$10.178							(6)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(7)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(10)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $42.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Michael Kirban 2010 Trust.

4. These shares are held by the Michael Kirban Revocable Trust.

5. The stock option is fully vested and currently exercisable.

6. The stock option is fully vested and currently exercisable.

7. The stock option vests in four equal annual installments beginning on November 27, 2022.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Michael Kirban	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Michael Kirban report on Form 4 for COCO?

The Form 4 reports a sale of 30,000 shares of Vita Coco Company, Inc. common stock executed on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share.

How many Vita Coco (COCO) shares does Michael Kirban beneficially own after the reported transaction?

The filing discloses 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly owned; these figures are as stated on the Form 4.

Were the sales made under a 10b5-1 plan for COCO insider Michael Kirban?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.

What stock options does Michael Kirban hold according to the Form 4?

The Form 4 lists multiple non-qualified stock options with strike prices ranging from $10.178 to $32.78, varying exercisable dates, and specified vesting schedules; some options are fully vested and currently exercisable.

Who signed the Form 4 for Michael Kirban?

The Form 4 was signed by Alison Klein, Attorney-in-Fact for Michael Kirban on 09/19/2025 as shown in the filing.